b
.
safety
and
efficacy
of
ironcontaining
iron
containing
drugs
.
the
act
also
authorizes
fda
to
regulate
the
marketing
of
any
products
to
help
ensure
that
the
products
are
safe
and
effective
for
their
intended
uses
.
`
new
drugs
'
may
not
be
introduced
into
interstate
commerce
unless
they
are
the
subject
of
approved
new
drug
applications
(
ndas25
usc
.
355a
.
the
act
defines
a
`
new
drug
'
as
:
(
1
)
any
drug
(
except
a
new
animal
drug
or
an
animal
feed
bearing
or
containing
a
new
animal
drug
)
the
composition
of
which
is
such
that
such
drug
is
not
generally
recognized
among
experts
qualified
by
scientific
training
and
experience
to
evaluate
the
safety
and
effectiveness
of
drugs
,
as
safe
and
effective
for
use
under
the
conditions
prescribed
,
recommended
,
or
suggested
in
the
labeling
thereof
;
or
(
2
)
any
drug
the
composition
of
which
is
such
that
such
drug
,
as
a
result
of
investigations
to
determine
its
safety
and
effectiveness
for
use
under
such
conditions
,
has
become
so
recognized
,
but
which
has
not
,
otherwise
than
in
such
investigations
,
been
used
to
a
material
extent
or
for
a
material
time
under
such
conditions
(
21
usc
.
321b
.
in
order
to
be
approved
,
an
nda
must
contain
adequate
data
to
demonstrate
that
the
drug
product
is
safe
and
effective
for
use
under
the
conditions
prescribed
,
recommended
,
or
suggested
in
the
labeling
(
21
usc
.
355d
.
in
addition
,
for
nda
approval
,
the
product
must
be
manufactured
using
current
good
manufacturing
practice
and
the
product
labeling
must
not
be
false
or
misleading
(
21
usc
.
355d
.
section
411
of
the
act
(
21
usc
.
350
)
provides
that
the
secretary
of
health
and
human
services
may
not
classify
any
natural
or
synthetic
vitamin
or
mineral
(
or
combination
thereof
)
as
a
drug
solely
because
it
exceeds
the
level
of
potency
which
the
secretary
determines
is
nutritionally
rational
or
useful
except
in
the
case
of
a
vitamin
,
mineral
,
other
ingredient
of
food
,
or
food
,
which
is
represented
for
use
by
individuals
in
the
treatment
or
management
of
specific
diseases
or
disorders
,
by
children
(
individuals
under
the
age
of
12
years
,
or
by
pregnant
or
lactating
women
.
most
of
the
ironcontaining
iron
containing
products
that
fda
regulates
are
considered
dietary
supplements
.
the
ironcontaining
iron
containing
products
that
fda
currently
regulates
as
drug
products
are
generally
prescription
products
and
are
so
designated
,
in
most
cases
,
because
they
contain
an
amount
of
folic
acid
that
exceeds
the
amount
in
which
folic
acid
may
be
used
as
a
food
additive
(
see
21
cfr
172
345
.
<
text
>
